Tarsus Pharmaceuticals In...
(TARS)
undefined
undefined%
At close: undefined
52.50
-0.23%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Cash & Equivalents | 224.95M | 71.66M | 171.33M | 168.13M | 57.95M | 2.35M |
Short-Term Investments | 2.50M | 145.37M | 483.00K | - | - | - |
Long-Term Investments | 631.00K | 371.00K | 663.00K | - | - | - |
Other Long-Term Assets | 1.51M | 585.00K | 463.00K | 81.00K | 6.00K | - |
Receivables | 17.71M | 3.58M | 92.00K | 20.00K | 36.00K | 4.00K |
Inventory | 3.11M | 4.76M | - | - | 20.00K | - |
Other Current Assets | 7.87M | 4.77M | 8.09M | 2.51M | 22.00K | 24.00K |
Total Current Assets | 256.13M | 225.38M | 175.95M | 170.66M | 58.03M | 2.38M |
Property-Plant & Equipment | 3.35M | 1.53M | 1.83M | 1.24M | 280.00K | 6.00K |
Goodwill & Intangibles | 3.87M | - | - | - | - | - |
Total Long-Term Assets | 9.36M | 2.49M | 2.96M | 1.32M | 286.00K | 6.00K |
Total Assets | 265.49M | 227.86M | 178.91M | 171.97M | 58.32M | 2.39M |
Account Payables | 18.15M | 5.50M | 2.86M | 2.24M | 456.00K | 175.00K |
Deferred Revenue | - | - | 697.00K | - | - | - |
Short-Term Debt | 398.00K | 721.00K | 1.31M | 282.00K | 64.00K | - |
Other Current Liabilities | 18.39M | 9.20M | 7.26M | 2.87M | 299.00K | 4.00K |
Total Current Liabilities | 36.94M | 15.43M | 11.48M | 5.39M | 819.00K | 179.00K |
Long-Term Debt | 31.33M | 19.43M | 585.00K | 549.00K | 100.00K | - |
Other Long-Term Liabilities | 233.00K | 100.00K | 114.00K | 56.00K | 63.40M | 3.56M |
Total Long-Term Liabilities | 31.57M | 19.53M | 699.00K | 605.00K | 63.50M | 3.56M |
Total Liabilities | 68.50M | 34.96M | 12.18M | 5.99M | 64.32M | 3.74M |
Total Debt | 31.73M | 20.16M | 1.89M | 831.00K | 164.00K | - |
Common Stock | 5.00K | 5.00K | 4.00K | 4.00K | 2.00K | 1K |
Retained Earnings | -244.66M | -108.76M | -46.67M | -32.84M | -6.03M | -1.36M |
Comprehensive Income | -2.00K | -74.00K | - | -171.97M | -63.40M | -1K |
Shareholders Equity | 196.99M | 192.90M | 166.73M | 165.98M | -6.00M | -1.35M |
Total Investments | 3.13M | 145.74K | 483.00K | - | - | - |